Precigen, Inc.
NASDAQPGEN heads into its June 18 earnings call with short sellers in an extended retreat — but still holding a position large enough to keep the stock structurally contested. Short interest has fallen from a peak above 21.8% of the free float in mid-April to just under 19.8% now. That decline spans roughly six weeks and represents a meaningful unwind. Yet 19.8% remains high in absolute…
Snapshot as of 27 May 2026
PGEN heads into its June 18 earnings call with short sellers in an extended retreat — but still holding a position large enough to keep the stock structurally contested. Short interest has fallen from a peak above…
PGEN enters the post-earnings window with an interesting tension: a stock still down 6% on the week, a short position that has been quietly unwinding, and a Q1 revenue beat that confirms Papzimeos is ramping faster…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PGEN — free to start on ORTEX.
Sign up for free →Open PGEN on ORTEX